Organigram Global (OGI) Research & Development (2018 - 2026)
Organigram Global's (OGI) quarterly Research & Development came in at $3.0 million in Q1 2026, up 61.51% year-on-year from $1.9 million in Q1 2025, and up 100.5% on a QoQ basis from $1.5 million in Q4 2025.
Organigram Global (OGI) Research & Development (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Research & Development data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Research & Development rose 61.51% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $8.0 million, a 62.22% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, changed N/A from the prior year.
- Research & Development for Q1 2026 stood at $3.0 million, up from $1.5 million in the prior quarter.
- Over the last five years, Research & Development for OGI reached as high as $3.0 million in Q1 2026 and fell as low as $1.5 million in Q4 2025.
- Historically, Research & Development has averaged $2.0 million across 3 years, with a median of $1.8 million in 2024.
- Across the five-year window, Research & Development fell 11.88% in 2025 and surged 61.51% in 2026, its largest moves.
- Year by year, Research & Development stood at $1.7 million in 2024, then fell by 11.88% to $1.5 million in 2025, then jumped by 100.5% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $3.0 million in Q1 2026, $1.5 million in Q4 2025, and $1.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Organigram Global | 119.01 Mn | 152.08 Mn | 28.97 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.70 Mn |
| May 31, 2021 | 10.92 Mn |
| Feb 28, 2021 | 6.81 Mn |
| Nov 30, 2020 | 646,000.00 |
| May 31, 2020 | 3.07 Mn |
| Feb 29, 2020 | 5.48 Mn |
| May 31, 2019 | 3.32 Mn |
| Feb 28, 2019 | 3.14 Mn |
| Nov 30, 2018 | 2.36 Mn |
| Aug 31, 2018 | 2.09 Mn |
| May 31, 2018 | 1.49 Mn |